A 35-year-old man presents with a clean surgical wound on his abdomen following elective cholecystectomy. On postoperative day 3, the wound shows signs of early infection with purulent discharge and surrounding erythema. Culture is pending. Which antibiotic is the drug of choice for empirical coverage of the most common surgical site infection pathogens in this scenario?

Explanation

## Empirical Antibiotic Coverage for Surgical Site Infections **Key Point:** Cefazolin is the first-line empirical agent for clean surgical site infections (SSIs) because it covers the most common pathogens — *Staphylococcus aureus* (including MSSA) and *Streptococcus pyogenes* — with excellent tissue penetration and wound bioavailability. ### Rationale for Cefazolin 1. **Spectrum & Mechanism**: First-generation cephalosporin; inhibits bacterial cell wall synthesis. Covers gram-positive cocci (MSSA, *Streptococcus*) and some gram-negative rods. 2. **Pharmacokinetics**: Achieves high concentrations in wound tissue and serum; half-life ~1.5–2 hours allows q8h dosing. 3. **Cost & Safety**: Inexpensive, well-tolerated, low resistance rates in community-acquired SSIs. 4. **Guideline Status**: Recommended by CDC and surgical societies as first-line empirical therapy for clean and clean-contaminated surgical wounds. ### Comparison with Distractors | Agent | Indication | Why Not Here | |-------|-----------|---------------| | **Cefazolin** | Clean SSI, MSSA coverage | ✓ **Correct choice** | | **Vancomycin** | MRSA, PCN allergy, severe infection | Overkill; reserved for MRSA risk or allergy | | **Fluoroquinolone** | Gram-negative coverage, oral step-down | Inadequate gram-positive coverage for acute SSI | | **Metronidazole** | Anaerobic coverage | No anaerobic pathogens in clean surgical wounds | **Clinical Pearl:** In a clean surgical wound without MRSA risk factors, MRSA colonization, or penicillin allergy, cefazolin remains the gold standard. Reserve vancomycin for MRSA-positive patients or β-lactam allergy. **High-Yield:** The "clean" classification means no break in sterile technique, no entry into GI/biliary/GU tract, and no major break in asepsis — hence *Staphylococcus aureus* (MSSA) and *Streptococcus* are the primary concern, not anaerobes or resistant gram-negatives.